Utah Medicaid and semaglutide
We could not read Utah Medicaid's current criteria, so its coverage of Wegovy and Zepbound for weight loss is not confirmed. KFF listed it as covering them in January 2026, a dated secondary source, and reported that funding was limited to fiscal year 2026, which ended June 30, 2026, so a change may have taken effect.
In 2025 Utah Medicaid paid for 10,366 semaglutide prescriptions (Ozempic, Rybelsus, Wegovy), 37% of its GLP-1 prescriptions and 45th of the 50 states and DC. It reimbursed $10.7 million before rebates, $1,028 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 9,617 | $9.9 million | $1,026 |
| Rybelsus | 700 | $728,987 | $1,041 |
| Wegovy | 49 | $61,867 | $1,263 |
Semaglutide in the states around Utah
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Utah | 19 | $39/moWellmedr | 10,366 | Medicaid Wegovy: Not confirmed (KFF) |
| Arizona | 19 | $39/moWellmedr | 8,154 | Medicaid Wegovy: No |
| Colorado | 19 | $39/moWellmedr | 26,771 | Medicaid Wegovy: No |
| Idaho | 19 | $39/moWellmedr | 29,015 | Medicaid Wegovy: Not covered (KFF) |
| Nevada | 19 | $39/moWellmedr | 44,949 | Medicaid Wegovy: No |
| New Mexico | 19 | $39/moWellmedr | 39,521 | Medicaid Wegovy: No |
| Wyoming | 19 | $39/moWellmedr | 593 | Medicaid Wegovy: No |



